Valuation (62%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 10.63 | 15.92 |
PEG Ratio (TTM) | -0.74 | 0.06 |
P/S Ratio (TTM) | 2.55 | 4.05 |
P/B Ratio (TTM) | 3.29 | 2.98 |
P/FCF Ratio (TTM) | 15.63 | 15.57 |
Price to 5YR AVG Earnings Ratio | 34.84 | 39.48 |
Price to 5YR AVG FCF Ratio | 13.15 | 22.56 |
Profitability (90%) |
Company | Industry |
---|---|---|
ROA (TTM) | 18.89% | 10.16% |
ROE (TTM) | 31.80% | 19.00% |
Net Profit Margin (TTM) | 23.94% | -45.98% |
ROIC 5YR AVG | 41.48% | 24.11% |
Growth (23%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -5.11% | -108.35% | -11.75% |
Revenue | -3.70% | 7.91% | 14.81% |
Net Income | -6.49% | -101.14% | -12.71% |
Cash Flow | -6.40% | 12.21% | 22.12% |
Health (65%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.70 | 1.76 |
Quick Ratio (TTM) | 0.70 | 1.65 |
D/E Ratio (TTM) | 0.15 | 17.21 |
Interest Coverage (TTM) | 28.77 | 18.36 |
Piotroski F-Score | 6 | 6 |
Altman Z-Score | 3.81 | 2.89 |
LTL to 5YR AVG FCF | 0.38 | 16.49 |
Shares Outstanding Growth 5YR AVG | -2.52% | 17.05% |